Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea

NCT03925441 · clinicaltrials.gov ↗
COMPLETED
Status
2
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie